Literature DB >> 32719020

Prepregnancy renal function and risk of preterm birth and related outcomes.

Ziv Harel1, Alison L Park2, Eric McArthur2, Michelle Hladunewich2, Jade S Dirk2, Ron Wald2, Amit X Garg2, Joel G Ray2.   

Abstract

BACKGROUND: Prepregnancy kidney dysfunction has been associated with preterm birth, which is the leading cause of neonatal morbidity and mortality; however, the relation is not well understood. We determined the risk of preterm birth in women with prepregnancy kidney dysfunction, defined using pregnancy-specific serum creatinine cut points.
METHODS: This population-based cohort study in the province of Ontario, Canada, involved women aged 16 to 50 years who had a singleton birth between 2006 and 2016 and measurement of serum creatinine within 10 weeks preceding their estimated conception date. The exposure was abnormally elevated prepregnancy serum creatinine, defined as greater than the 95th percentile (> 77 μmol/L), a value derived from a population-based sample of women without known kidney disease who became pregnant soon after the measurement was obtained. The main outcome was any preterm birth from 23 to 36 weeks' gestation. Secondary outcomes included provider-initiated preterm birth before 37 weeks' gestation and spontaneous preterm birth before 37 weeks.
RESULTS: Among 55 946 pregnancies, preterm birth before 37 weeks' gestation occurred in 3956 women (7.1%). The risk of preterm birth before 37 weeks was higher among women with prepregnancy creatinine above the 95th percentile, relative to those with prepregnancy creatinine at or below the 95th percentile (9.1% v. 7.0%; adjusted relative risk [RR] 1.23, 95% confidence interval [CI] 1.09 to 1.38). The effect was significant for provider-initiated preterm birth (adjusted RR 1.30, 95% CI 1.11 to 1.52) but not for spontaneous preterm birth (adjusted RR 1.12, 95% CI 0.91 to 1.37).
INTERPRETATION: Given that prepregnancy kidney dysfunction conferred an increased risk of preterm birth, measurement of serum creatinine (a relatively inexpensive blood test) may form part of the assessment of risk for preterm birth among those planning pregnancy.
© 2020 Joule Inc. or its licensors.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32719020      PMCID: PMC7828914          DOI: 10.1503/cmaj.200089

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  32 in total

1.  Intrauterine growth restriction increases morbidity and mortality among premature neonates.

Authors:  Thomas J Garite; Reese Clark; James A Thorp
Journal:  Am J Obstet Gynecol       Date:  2004-08       Impact factor: 8.661

2.  The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.

Authors:  Giovana S Di Marco; Stefan Reuter; Uta Hillebrand; Susanne Amler; Maximilian König; Etienne Larger; Hans Oberleithner; Eva Brand; Hermann Pavenstädt; Marcus Brand
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

3.  Pregnancy in women with kidney disease.

Authors:  A I Katz; J M Davison; J P Hayslett; E Singson; M D Lindheimer
Journal:  Kidney Int       Date:  1980-08       Impact factor: 10.612

4.  Chronic renal disease and pregnancy outcome.

Authors:  F G Cunningham; S M Cox; T W Harstad; R A Mason; J A Pritchard
Journal:  Am J Obstet Gynecol       Date:  1990-08       Impact factor: 8.661

5.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

6.  Estimated reductions in provider-initiated preterm births and hospital length of stay under a universal acetylsalicylic acid prophylaxis strategy: a retrospective cohort study.

Authors:  Joel G Ray; Emily Bartsch; Alison L Park; Prakesh S Shah; Susie Dzakpasu
Journal:  CMAJ Open       Date:  2017-06-23

7.  Risk of Adverse Pregnancy Outcomes in Women with CKD.

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Rossella Attini; Federica Neve Vigotti; Stefania Maxia; Nicola Lepori; Milena Tuveri; Marco Massidda; Cecilia Marchi; Silvia Mura; Alessandra Coscia; Marilisa Biolcati; Pietro Gaglioti; Michele Nichelatti; Luciana Pibiri; Giuseppe Chessa; Antonello Pani; Tullia Todros
Journal:  J Am Soc Nephrol       Date:  2015-03-12       Impact factor: 10.121

8.  Kidney function and future risk for adverse pregnancy outcomes: a population-based study from HUNT II, Norway.

Authors:  John Munkhaugen; Stian Lydersen; Pål Richard Romundstad; Tor-Erik Widerøe; Bjørn Egil Vikse; Stein Hallan
Journal:  Nephrol Dial Transplant       Date:  2009-07-03       Impact factor: 5.992

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

Review 10.  A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy.

Authors:  Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Michele Giannattasio; Gina Gregorini; Franca Giacchino; Rossella Attini; Valentina Loi; Monica Limardo; Linda Gammaro; Tullia Todros; Giorgina Barbara Piccoli
Journal:  J Nephrol       Date:  2016-03-17       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.